Table 3.
References | Rossi et al. [22] | Chan et al. [4] | Chan et al. [5] | Gill et al. [8] | Lobenhoffer et al. [15] | Siegler et al. [24] | Kayali et al. [12] | Duan et al. [6] | Pogliacomi et al. [19] | Asik et al. [1] | Glabbeek et al. [26] | Roerdink et al. [21] |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Selection | ||||||||||||
(1) Representativeness of the exposed cohort | ||||||||||||
(a) Truly representative of the average patient in the community | ||||||||||||
(b) Somewhat representative of the average patient in the community | * | * | * | * | * | * | * | * | * | * | ||
(c) Selected group of users, e.g., nurses, volunteers | * | * | ||||||||||
(d) No description of the derivation of the cohort | ||||||||||||
(2) Selection of the non-exposed cohort | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
(a) Drawn from the same community as the exposed cohort | ||||||||||||
(b) Drawn from a different source | * | |||||||||||
(c) No description of the derivation of the non-exposed cohort | ||||||||||||
(3) Ascertainment of exposure | ||||||||||||
(a) Secure record (e.g., surgical records) | * | * | * | * | * | * | * | * | * | * | * | * |
(b) Structured interview | ||||||||||||
(c) Written self-report | ||||||||||||
(d) No description | ||||||||||||
(4) Demonstration that outcome of interest was not present at start of study | ||||||||||||
(a) Yes | * | * | * | * | * | * | * | * | * | * | * | * |
(b) No | ||||||||||||
Comparability | ||||||||||||
(1) Comparability of cohorts on the basis of the design or analysis | ||||||||||||
(a) Study controls for scores | * | * | * | * | * | * | * | * | * | * | * | * |
(b) Study controls for any additional factor | ||||||||||||
Outcome | ||||||||||||
(1) Assessment of outcome | ||||||||||||
(a) Independent blind assessment | ||||||||||||
(b) Record linkage | * | * | * | * | * | * | * | * | * | * | * | * |
(c) Self-report | ||||||||||||
(d) No description | ||||||||||||
(2) Was follow-up long enough for outcomes to occur | ||||||||||||
(a) Yes (select an adequate follow-up period for outcome of interest) | * | * | * | * | * | * | * | * | * | * | * | * |
(b) No | ||||||||||||
(3) Adequacy of follow-up of cohorts | ||||||||||||
(a) Complete follow-up—all subjects accounted for | * | * | * | * | * | * | * | * | * | * | ||
(b) Subjects lost to follow-up unlikely to introduce bias | n = 7* | 25%* | ||||||||||
(c) Follow-up rate and no description of those lost | ||||||||||||
(d) No statement |
NA not applicable
* means yes